Drug Manufacturers—General Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2166 |  MAZE Maze Therapeutics, Inc. - Common Stock | 25.88 USD | -1.41% | -4.43% | +6.68% | -42.53% | 1.44 B USD | ||
| 2169 |  RAPP Rapport Therapeutics, Inc. - Common Stock | 29.85 USD | -3.27% | -10.44% | -31.14% | +13.97% | 1.43 B USD | ||
| 2823 |  CBIO Crescent Biopharma, Inc. - Common Stock | 14.12 USD | +4.67% | -2.49% | -28.14% | +15.93% | 524.47 M USD | ||
| 3004 |  EIKN Eikon Therapeutics, Inc. - Common Stock | 7.50 USD | -0.53% | -0.66% | -29.38% | -56.01% | 406.24 M USD | ||
| 3388 |  AMRN Amarin Corporation plc - American Depositary Shares, each repre | 11.99 USD | -0.25% | -7.77% | -15.98% | -22.94% | 253.26 M USD | ||
| 3397 |  UPB Upstream Bio, Inc. - Common Stock | 4.55 USD | -1.30% | -6.76% | -22.35% | -77.02% | 249.21 M USD | ||
| 3424 |  QTTB Q32 Bio Inc. - Common Stock | 8.09 USD | +1.25% | -3.11% | -26.45% | +129.83% | 240.83 M USD | ||
| 3863 |  PLYX Polaryx Therapeutics, Inc. - Common Stock | 2.00 USD | -4.31% | -2.44% | -2.91% | -95.56% | 99.69 M USD | ||
| 3886 |  OKUR OnKure Therapeutics, Inc. - Class A Common Stock | 2.30 USD | -2.13% | -10.51% | -32.15% | -6.12% | 93.14 M USD | ||
| 3965 |  PTHS Pelthos Therapeutics Inc. Common Stock | 20.80 USD | -2.58% | +1.41% | -9.88% | -14.79% | 79.63 M USD | ||
| 3990 |  OSTX OS Therapies Incorporated Common Stock | 1.62 USD | +5.88% | -0.61% | -12.90% | +40.87% | 74.72 M USD | ||
| 4178 |  EXOZ eXoZymes Inc. - Common Stock | 5.33 USD | -3.79% | -7.47% | -13.75% | -45.05% | 49.47 M USD | ||
| 4183 |  VBIO Valion Bio, Inc. - Common stock | 2.21 USD | +0.91% | -13.33% | -7.14% | +84.17% | 49.04 M USD | ||
| 4193 |  DWTX Dogwood Therapeutics, Inc. - Common Stock | 1.41 USD | -1.40% | -7.84% | -27.32% | -53.00% | 47.93 M USD | ||
| 4312 |  IBO Impact BioMedical, Inc. Common Stock | 4.12 USD | -9.25% | -21.82% | +758.33% | +836.36% | 35.20 M USD | ||
| 4378 |  MIRA MIRA Pharmaceuticals, Inc. - Common Stock | 0.70 USD | -1.41% | -4.11% | -11.39% | -48.15% | 29.42 M USD | ||
| 4415 |  SCLX Scilex Holding Company - Common Stock | 2.96 USD | -15.19% | -33.03% | -42.97% | -63.59% | 25.14 M USD | ||
| 4734 |  APUS Apimeds Pharmaceuticals US, Inc. Common Stock | 5.43 USD | -22.09% | +32.44% | +136.09% | +314.50% | 8.19 M USD | ||
| 4786 |  MDCX Medicus Pharma Ltd. - Common Stock | 0.10 USD | -37.50% | -37.50% | -41.18% | -91.53% | 6.32 M USD | ||
| 4829 |  QCLS Q/C Technologies, Inc. - Common Stock | 0.64 USD | +1.59% | -17.95% | -63.22% | -83.42% | 5.24 M USD |
Nouvelles Drug Manufacturers—General Stocks
SOPHiA GENETICS et Myriad Genetics collaborent pour faire progresser une nouvelle technologie d’indice d’instabilité génomique spécifique au cancer de la prostate
Cantor Fitzgerald relève son objectif de cours sur Pfizer
Northern Discovery acquiert le projet cuivre-or Cibola en Colombie-Britannique
Cantor Fitzgerald relève son objectif de cours sur Merck avec une perspective 2027
Cantor Fitzgerald abaisse l’objectif de cours de Bristol-Myers Squibb à 53$
Cantor Fitzgerald relève son objectif de cours sur Eli Lilly
Cantor Fitzgerald relève son objectif de cours sur Amgen grâce à la solidité du portefeuille
Gainers Drug Manufacturers—General Stocks
 LIMNW Liminatus Pharma, Inc. - Warrants | 0.0497 | +34.32% |
 MANE Veradermics, Incorporated Common Stock | 126.68 | +13.94% |
OSTX OS Therapies Incorporated Common Stock | 1.62 | +5.88% |
 KAPA Kairos Pharma, Ltd. Common Stock | 0.93 | +5.68% |
CBIO Crescent Biopharma, Inc. - Common Stock | 14.12 | +4.67% |
 GENB Generate Biomedicines, Inc. - Common Stock | 13.99 | +3.10% |
QCLS Q/C Technologies, Inc. - Common Stock | 0.64 | +1.59% |
 CGON CG Oncology, Inc. - Common stock | 63.26 | +1.41% |
Losers Drug Manufacturers—General Stocks
MDCX Medicus Pharma Ltd. - Common Stock | 0.10 | -37.50% |
APUS Apimeds Pharmaceuticals US, Inc. Common Stock | 5.43 | -22.09% |
 ERNAW Ernexa Therapeutics Inc. - Warrants | 0.0319 | -16.05% |
SCLX Scilex Holding Company - Common Stock | 2.96 | -15.19% |
IBO Impact BioMedical, Inc. Common Stock | 4.12 | -9.25% |
 PPCB Propanc Biopharma, Inc. - Common Stock | 0.47 | -6.00% |
 DCOY Decoy Therapeutics Inc. - Common Stock | 1.52 | -5.59% |
 VIVS VivoSim Labs, Inc. - Common Stock | 0.18 | -5.26% |